M.D., Chief Medical Officer, GRAIL
Biography
Jeffrey M. Venstrom, MD, is a physician-scientist with expertise in oncology, hematology, and drug/diagnostic development. Dr. Venstrom is currently developing new integrated evidence strategies for multi-cancer early detection, the biggest unmet need in Oncology.
Prior to joining GRAIL, he served as Chief Medical Partner at Genentech, where he led new Health Equity strategies, and developed an innovation incubator for Medical Affairs, across Oncology and Neuroscience. During his 8 years at Roche, Dr. Venstrom established and led the Global Hematology Biomarker Franchise at Genentech and Roche where he focused on biomarker and companion diagnostic development for early and late-stage molecules in hematology/oncology and immunology. Prior to joining Genentech/Roche, Dr. Venstrom was the Krishnamurthi Endowed Chair in Hematologic Malignancies at The University of California, San Francisco. In addition to clinical care of cancer patients, he led a grant-funded research lab and served as principal investigator for several industry-sponsored translational research trials and collaborations.
Session Abstract – PMWC 2023 Silicon Valley
Track 4 - January 26 9.00 A.M.-4.30 P.M.
Track Chair: Cindy Perettie, Roche
- PMWC 2023 Award Ceremony
- Luis Alberto Diaz Jr., MSK
- Razelle Kurzrock, Medical College of Wisconsin - Non-invasive Liquid Biopsy Techniques (PANEL)
Chair: Razelle Kurzrock, Medical College of Wisconsin
- Apostolia Tsimberidou, MD Anderson
- Mandana Kamgar, MD Medical College of Wisconsin
- Mina Nikanjam, UCSD
- Ash Alizadeh, Stanford University - Liquid Biopsy Challenges and Limitations (PANEL)
Chair: Victor Lin, Mary Bird Perkins
- Luis Alberto Diaz Jr., MSK
- Maximilian Diehn, Stanford
- Dana Dilbeck, Agilent
- Emma Shtivelman, Cancer Commons - Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL)
Chair: Cindy Perettie, Roche Diagnostics
- Eric Peters, Genenetch
- Andrew Mckenzie, Sarah Cannon
- Yang Pan, Gilead
- Alan Sandler, Mirati Therapeutics - Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing
Chair: Tom Beer, Exact Sceinces
- Liquid Biopsy for Early Cancer Detection (PANEL)
Chair: Priti Hegde, Foundation Medicine
- Daniel Kim, UCSC
- Mike Nolan, Freenome
- Jeffrey Venstrom, Grail Bio
- Kathryn Phillips, UCSF
- Lon Castle, eviCore healthcare
- Tom Beer, Exact Sciences - Liquid Biopsy for Minimal Residual Disease (PANEL)
Chair: Minetta Liu, Natera
- Peter Bach, Delfi diagnostics
- Laura Vantveer, UCSF
- Susan Bobulsky, Adaptive
- Joshua Cohen, Johns Hopkins
- PMWC Showcase
- Harmeet Dhani, Biological Dynamics
- Varsha Rao, Claret Bio - PMWC NCI Showcase
- Xianghong Jasmine Zhou, EarlyDiagnostics
